These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 953963)

  • 1. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.
    Stein JA; Adler A; Efraim SB; Maor M
    Cancer; 1976 Sep; 38(3):1171-87. PubMed ID: 953963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
    Adler A; Stein JA; Ben-Efraim S
    Cancer; 1980 Apr; 45(8):2061-73. PubMed ID: 7370952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
    Adler A; Stein JA; Ben-Efraim S
    Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
    Das SN; Khanna NN; Khanna S
    Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
    J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
    [No Abstract]   [Full Text] [Related]  

  • 9. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immune competence of patients with Crohn's disease (author's transl)].
    Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
    Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
    Lee YT
    J Surg Oncol; 1984 Nov; 27(3):135-40. PubMed ID: 6492808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
    Das SN; Khanna NN; Khanna S
    Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.
    Wanebo HJ; Rosen PP; Thaler T; Urban JA; Oettgen HF
    Ann Surg; 1976 Sep; 184(3):258-67. PubMed ID: 962394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity.
    Baskies AM; Chretien PB; Weiss JF; Makuch RW; Beveridge RA; Catalona WJ; Spiegel HE
    Cancer; 1980 Jun; 45(12):3050-60. PubMed ID: 7388749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
    Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
    Cancer Immunol Immunother; 1986; 21(1):6-11. PubMed ID: 3632917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary immunodeficiency in miliary tuberculosis.
    Uberoi S; Malaviya AN; Chattopadhyay C; Kumar R; Shrinivas
    Clin Exp Immunol; 1975 Dec; 22(3):404-8. PubMed ID: 1083782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
    Magrath IT; Simon RM
    Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.